Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dialysis01:27

Dialysis

322
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
322
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

173
Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
173
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

95
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
95
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

396
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
396
Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

2.4K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.4K
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

192
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
192

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient and nurse trainer perspectives on a structured PD training programme: A process evaluation of the TEACH-PD feasibility trial.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2026
Same author

Trends in peritoneal dialysis demographics, peritonitis and HD transfer in Australia from 2013-2022.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2025
Same author

Nursing management of catheter-related non-infectious complications of PD: Your questions answered.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2024
Same author

Multi-center, pragmatic, cluster-randomized, controlled trial of standardized peritoneal dialysis (PD) training versus usual care on PD-related infections (the TEACH-PD trial): trial protocol.

Trials·2023
Same author

Understanding the practice patterns of nephrology nurse practitioners in Australia.

Journal of renal care·2022
Same author

Chronic lithium toxicity.

Australian prescriber·2022

Related Experiment Video

Updated: Jul 9, 2025

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

15.3K

Prescribing and peritoneal dialysis.

Frank Reimann1, Melinda Tomlins2

  • 1Manning Base Hospital, Taree, NSW.

Australian Prescriber
|December 6, 2023
PubMed
Summary
This summary is machine-generated.

Peritoneal dialysis offers home-based flexibility for end-stage kidney disease patients. Careful management of fluid balance, drug dosing, and infection prevention is crucial for successful treatment and preserving residual kidney function.

Keywords:
dialysis solutionsend-stagefailurekidneykidney diseaseperitoneal dialysis

More Related Videos

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

2.6K
Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion
06:09

Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion

Published on: May 23, 2025

82

Related Experiment Videos

Last Updated: Jul 9, 2025

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

15.3K
A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

2.6K
Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion
06:09

Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion

Published on: May 23, 2025

82

Area of Science:

  • Nephrology
  • Internal Medicine
  • Renal Replacement Therapy

Background:

  • Peritoneal dialysis (PD) is a home-based treatment for end-stage kidney disease (ESKD).
  • PD provides flexibility and independence compared to hemodialysis, despite lower solute and fluid clearance efficiency.
  • Patient-specific peritoneal transport characteristics influence PD prescription and outcomes.

Purpose of the Study:

  • To review key considerations for optimizing peritoneal dialysis therapy.
  • To highlight management strategies for common challenges in PD patients.
  • To emphasize the importance of preserving residual kidney function and preventing complications.

Main Methods:

  • Review of current literature and clinical guidelines related to peritoneal dialysis.
  • Analysis of factors affecting PD prescription, drug administration, and fluid management.
  • Discussion of complications and preventive measures, including infections and metabolic effects.

Main Results:

  • Peritoneal transport characteristics are critical for tailoring PD prescriptions.
  • Drug dosing requires adherence to kidney disease recommendations, with specific considerations for intraperitoneal antibiotics.
  • Fluid overload is a common issue, and preserving residual kidney function is essential.
  • High glucose dialysis solutions can cause adverse metabolic effects.
  • PD-related complications, such as infections, may necessitate a switch to hemodialysis.
  • Antifungal prophylaxis is recommended during antibiotic use to prevent fungal peritonitis.

Conclusions:

  • Effective peritoneal dialysis management requires attention to individual patient needs and potential complications.
  • Preserving residual kidney function and preventing infections are paramount for long-term PD success.
  • Close collaboration between patients, healthcare providers, and dialysis units is essential for optimal care.